Cancer Immunotherapies

被引:41
作者
Bergman, Philip J. [1 ,2 ,3 ]
机构
[1] VCA, Clin Studies, Los Angeles, CA USA
[2] Katonah Bedford Vet Ctr, 546 N Bedford Rd, Bedford Hills, NY 10507 USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
关键词
Cancer; Immunotherapy; Cancer vaccine; Monoclonal antibody; Canine; Feline; ENCAPSULATED MURAMYL TRIPEPTIDE; ORAL MALIGNANT-MELANOMA; REGULATORY T-CELLS; SURGERY ADJUVANT TREATMENTS; CYTOKINE-ENHANCED VACCINE; SUICIDE GENE-THERAPY; RECOMBINANT FELINE INTERFERON; SPONTANEOUS CANINE MELANOMA; MEDIATED IMMUNE-RESPONSES; BACILLUS-CALMETTE-GUERIN;
D O I
10.1016/j.cvsm.2019.04.010
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The enhanced understanding of immunology experienced over the last 4 decades afforded through the tools of molecular biology has recently translated into cancer immunotherapy becoming one of the most exciting and rapidly expanding fields. Human cancer immunotherapy is now recognized as one of the pillars of treatment alongside surgery, radiation, and chemotherapy. The field of veterinary cancer immunotherapy has also rapidly advanced in the last decade with a handful of commercially available products and a plethora of investigational cancer immunotherapies that will hopefully expand the veterinary oncology treatment toolkit over time.
引用
收藏
页码:881 / +
页数:23
相关论文
共 214 条
[1]   Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy [J].
Adelfinger, Marion ;
Bessler, Simon ;
Frentzen, Alexa ;
Cecil, Alexander ;
Langbein-Laugwitz, Johanna ;
Gentschev, Ivaylo ;
Szalay, Aladar A. .
VIRUSES-BASEL, 2015, 7 (07) :4075-4092
[2]   Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model [J].
Akhtar, N ;
Padilla, ML ;
Dickerson, EB ;
Steinberg, H ;
Breen, M ;
Auerbach, R ;
Helfand, SC .
NEOPLASIA, 2004, 6 (02) :106-116
[3]   Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma [J].
Alexander, AN ;
Huelsmeyer, MK ;
Mitzey, A ;
Dubielzig, RR ;
Kurzman, ID ;
MacEwen, EG ;
Vail, DM .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (04) :433-442
[4]   Vaccination for Invasive Canine Meningioma Induces In Situ Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity [J].
Andersen, Brian M. ;
Pluhar, G. Elizabeth ;
Seiler, Charles E. ;
Goulart, Michelle R. ;
SantaCruz, Karen S. ;
Schutten, Melissa M. ;
Meints, Joyce P. ;
O'Sullivan, M. Gerard ;
Bentley, R. Timothy ;
Packer, Rebecca A. ;
Thomovsky, Stephanie A. ;
Chen, Annie V. ;
Faissler, Dominik ;
Chen, Wei ;
Hunt, Matthew A. ;
Olin, Michael R. ;
Ohlfest, John R. .
CANCER RESEARCH, 2013, 73 (10) :2987-2997
[5]  
Anderson Katie L, 2015, Vet Sci, V2, P363, DOI 10.3390/vetsci2040363
[6]   A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations [J].
Angstadt, Andrea Y. ;
Thayanithy, Venugopal ;
Subramanian, Subbaya ;
Modiano, Jaime F. ;
Breen, Matthew .
CANCER GENETICS, 2012, 205 (11) :572-587
[7]   Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks [J].
Arendt, M. ;
Nasir, L. ;
Morgan, I. M. .
VETERINARY AND COMPARATIVE ONCOLOGY, 2009, 7 (03) :153-161
[8]   Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles [J].
Autio, Karoliina P. M. ;
Ruotsalainen, Janne J. ;
Anttila, Marjukka O. ;
Niittykoski, Minna ;
Waris, Matti ;
Hemminki, Akseli ;
Vaha-Koskela, Markus J. V. ;
Hinkkanen, Ari E. .
BMC VETERINARY RESEARCH, 2015, 11
[9]  
Banker D D, 2001, Indian J Med Sci, V55, P651
[10]   Cancer immunotherapy [J].
Baxevanis, Constantin N. ;
Perez, Sonia A. ;
Papamichail, Michael .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2009, 46 (04) :167-189